Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

February 01, 1997; 48 (2) Article

Indictment of the microglia as the villain in multiple sclerosis

S. Sriram, M. Rodriguez
First published February 1, 1997, DOI: https://doi.org/10.1212/WNL.48.2.464
S. Sriram
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Rodriguez
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Indictment of the microglia as the villain in multiple sclerosis
S. Sriram, M. Rodriguez
Neurology Feb 1997, 48 (2) 464-470; DOI: 10.1212/WNL.48.2.464

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
80

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Over the past decade, considerable attention has focused on the theory that MS is an autoimmune disease mediated by T cells specific for neural autoantigens. [1,2] Infectious agents may play a role in triggering an autoimmune process in a susceptible individual. [3,4] If so, this would reconcile the roles of environmental and genetic factors in the development of MS. The existence of structural similarities between viral antigens and autoantigens (viral mimicry) and the possibility that viral products (super antigens) can amplify T-cell populations have suggested mechanisms by which an infectious agent such as a virus can initiate an autoimmune process. [5,6] An essential element of both hypotheses (molecular mimicry and superantigens) is the expansion and targeting of autoreactive CD4+ T cells to the CNS. Hence, understanding T-cell receptor (TCR) gene usage of autoreactive T cells and their cytokine secretion profile has been a central focus of interest. We propose a model of CNS demyelination that is not predicated upon the continued presence of autoreactive T cells. Instead, we suggest that microglial activation is a central element in CNS demyelination and that the oligodendrocyte-myelin unit is the target. Understanding the nature of microglial activation is likely to offer therapeutic insights to the treatment of MS.

In contrast to autoantibody-mediated autoimmune disease, evidence for the role of autoreactive T cells in autoimmune disease has been difficult to prove. This is in part because T-cell reactivity to autoantigens is present in the normal healthy population and there is no system to test the pathogenicity of autoreactive T cells. Nonetheless, rheumatoid arthritis, MS, inflammatory bowel disease, and insulin-dependent diabetes mellitus are thought to represent T-cell-mediated autoimmune disease. In this paradigm, the end-organ damage is not the result of antibodies to self-antigens but due in part to a delayed type hypersensitivity, cytokines, and cytotoxic T-cell …

View Full Text

AAN Members

We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.

Google Safari Microsoft Edge Firefox

Click here to login

AAN Non-Member Subscribers

Click here to login

Purchase access

For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)

Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here 

Purchase
Individual access to articles is available through the Add to Cart option on the article page.  Access for 1 day (from the computer you are currently using) is US$ 39.00.  Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means.  The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use.  Distributing copies (electronic or otherwise) of the article is not allowed.

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Pitfalls in the similarities between EAE and MS.
    • Primary role for macrophages/microglial cells in the development of inflammatory demyelinating disease.
    • Proposed model of CNS demyelination.
    • Acknowledgments
    • REFERENCES
  • Figures & Data
  • Info & Disclosures
Advertisement

Association of Neurofilament Light With the Development and Severity of Parkinson Disease

Dr. Rodolfo Savica and Dr. Parichita Choudhury

► Watch

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Articles
    Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis
    Suhayl Dhib-Jalbut et al.
    Neurology, June 04, 2007
  • Articles
    Inflammatory, immune, and viral aspects of inclusion-body myositis
    Marinos C. Dalakas et al.
    Neurology, December 16, 2005
  • Articles
    Human T-cell response to myelin basic protein peptide (83-99): Extensive heterogeneity in antigen recognition, function, and phenotype
    B. Hemmer, M. Vergelli, L. Tranquill et al.
    Neurology, October 01, 1997
  • Cytokine Networks in Multiple Sclerosis
    Circulating adhesion molecules and inflammatory mediators in demyelination
    A review
    Hans-Peter Hartung, Juan J. Archelos, Jurgen Zielasek et al.
    Neurology, June 01, 1995
Neurology: 100 (20)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise